FDA Recalls Finder
News:
Site opened 3/25/2009. Welcome!
Home
Help
Search
Tags
Login
Register
FDA Recalls Finder
»
General Category
»
Press Releases From the FDA
»
FDA Approves New Treatment for Chronic Lymphocytic Leukemia
« previous
next »
Print
Pages: [
1
]
Author
Topic: FDA Approves New Treatment for Chronic Lymphocytic Leukemia (Read 69 times)
recalls-bot
Global Moderator
Hero Member
Posts: 1707
FDA Approves New Treatment for Chronic Lymphocytic Leukemia
«
on:
October 26, 2009, 05:09:05 PM »
FDA Approves New Treatment for Chronic Lymphocytic Leukemia
26 October 2009, 4:27 pm
The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow.
Source:
Food and Drug Administration--Press Releases
Logged
Print
Pages: [
1
]
« previous
next »
Tags:
FDA Recalls Finder
»
General Category
»
Press Releases From the FDA
»
FDA Approves New Treatment for Chronic Lymphocytic Leukemia